Atrial fibrillation: current status and challengesFOX, Keith A. A.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 3, pp 171-186, issn 1272-9949, 16 p.Article

Depression and distressed (Type D) personality: what is their impact on cardiovascular outcomes?DENOLLET, Johan.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 2, pp 115-125, issn 1272-9949, 11 p.Article

Contemporary trends in the pharmacological management of heart failureSWEDBERG, Karl.Dialogues in cardiovascular medicine. 2011, Vol 16, Num 2, pp 85-98, issn 1272-9949, 14 p.Article

Art and the Heart: Details, details: of surgery and paintingMANCHE, Alex.Dialogues in cardiovascular medicine. 2011, Vol 16, Num 2, pp 123-127, issn 1272-9949, 5 p.Article

Myocardial ischemia as a multifactorial disease: what is new?MARZILLI, Mario; HUQI, Alda; CAPOZZA, Paola et al.Dialogues in cardiovascular medicine. 2011, Vol 16, Num 3, pp 190-195, issn 1272-9949, 6 p.Article

What is the role of increased heart rate in acute coronary syndromes?LOPEZ-SENDON, José; FERRARI, Roberto.Dialogues in cardiovascular medicine. 2010, Vol 15, Num 3, pp 203-210, issn 1272-9949, 8 p.Article

Trails of Discovery: Aldosterone antagonists: a model of translational medicineFITZGERALD, Nicola; FITZGERALD, J. Desmond.Dialogues in cardiovascular medicine. 2009, Vol 14, Num 2, pp 118-125, issn 1272-9949, 8 p.Article

Should cardiovascular disease prevention be undertaken by politicians?GRECO, Donato; LAURENDI, Giovanna.Dialogues in cardiovascular medicine. 2009, Vol 14, Num 2, pp 112-118, issn 1272-9949, 7 p.Article

Does cell therapy for myocardial infarction and heart failure work?WOLLERT, Kai C; DREXLER, Helmut.Dialogues in cardiovascular medicine. 2009, Vol 14, Num 1, pp 37-43, issn 1272-9949, 7 p.Article

Imaging versus biopsy-how do you best diagnose myocarditis?MAHRHOLDT, Heiko; YILMAZ, Ali; SECHTEM, Udo et al.Dialogues in cardiovascular medicine. 2009, Vol 14, Num 3, pp 178-186, issn 1272-9949, 9 p.Article

Matters @ Heart : Dr John H. Gibbon and the first heart-lung machine : Ischemic heart disease in the older patientBING, Richard J.Dialogues in cardiovascular medicine. 2008, Vol 13, Num 1, pp 51-53, issn 1272-9949, 3 p.Article

The French paradoxTUNSTALL-PEDOE, Hugh.Dialogues in cardiovascular medicine. 2008, Vol 13, Num 3, pp 159-179, issn 1272-9949, 21 p.Article

How do gender differences affect cardiovascular risk factors?SCHENCK-GUSTAFSSON, Karin.Dialogues in cardiovascular medicine. 2008, Vol 13, Num 2, pp 120-126, issn 1272-9949, 7 p.Article

What are the regulatory and economic challenges posed by drug-eluting stents?SHAH, Bimal R; SCHULMAN, Kevin A.Dialogues in cardiovascular medicine. 2008, Vol 13, Num 4, pp 267-272, issn 1272-9949, 6 p.Article

Clinical role of advanced imaging in cardiologyPRASAD, Sanjay K; PENNELL, Dudley J.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 2, pp 87-101, issn 1272-9949, 15 p.Article

Cross-talk between the brain and other organs : is the brain to blame for hypertension? : Hypertension: Cross-talk between the brain and other organsPATON, Julian F; RAIZADA, Mohan K.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 3, pp 163-179, issn 1272-9949, 17 p.Article

Hypertension, SNS overactivity, and the brain : how do they interact with peripheral organs and how do they impact psychological influences, stress, and target-organ damage? : Hypertension: Cross-talk between the brain and other organsESTER, Murray D; LAMBERT, Elisabeth A.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 3, pp 183-191, issn 1272-9949, 9 p.Article

The cardiovascular manifestations of HIV infection : HIV & cardiovascular diseaseLIPSHULTZ, Steven E; FISHER, Stacy D; MILLER, Trade L et al.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 1, pp 5-23, issn 1272-9949, 19 p.Article

What can be done about effusive tuberculous pericarditis in HIV-seropositive patients? : HIV & cardiovascular diseaseMALILT, Adam S; HAKIM, James G.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 1, pp 48-55, issn 1272-9949, 8 p.Article

Performance and endurance in sport: can it all be explained by metabolism and its manipulation?JEUKENDRUP, Asker E.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 1, pp 40-45, issn 1272-9949, 6 p.Article

How do we balance risk and benefit in a population at risk of both stroke and bleeding?KIRCHHOF, Paulus.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 3, pp 197-205, issn 1272-9949, 9 p.Article

Is warfarin obsolete in the era of new anticoagulants?MAHAFFEY, Kenneth W.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 3, pp 206-213, issn 1272-9949, 8 p.Article

The Brokenhearted: Cardiovascular Disease and DepressionDialogues in cardiovascular medicine. 2012, Vol 17, Num 2, issn 1272-9949, 81 p.Serial Issue

How should we treat depression in patients with cardiovascular disease?KRONISH, Ian M; KRUPKA, David J; DAVIDSON, Karina W et al.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 2, pp 126-133, issn 1272-9949, 8 p.Article

Which drugs and devices can we use for protection against thromboembolic stroke?JOHN CAMM, A.Dialogues in cardiovascular medicine. 2012, Vol 17, Num 3, pp 189-196, issn 1272-9949, 8 p.Article